Another @asco -GU poster and another set of data points and learnings from Georgetown Lombardi Michael B. Atkins, MD. Join us at Session C: Abstract 448; Poster Board J9; tomorrow 1/27, 7-8:10 am meetings.asco.org/abstracts-pres… @danafarber Sabina Signoretti, MD

Landmark moment in the history of #RCC Toni Choueiri, MD revealing the 1st ever OS benefit for adjuvant treatment in RCC with pembro 38% decrease in the risk of death. Huge! #GU24 OncoAlert

Thrilled to be selected as JCO Global Oncology Top Reviewer for the year 2023. Grateful for all the support from mentors Hongcheng Zhu 祝鸿程 Prof. Eva Segelov #Global #Oncology ASCO Reviewer Mentoring Program was an incredible experience. Consider applying app.smartsheet.com/b/form/19169a6…

We all are Dana-Farber Lank Center for Genitourinary Oncology proud of you Renee Maria Saliby #RMS matching in one of the best IM programs in the world Yale Internal Medicine —thank you Mark D. Siegel for your inclusivity!

⭐️Over the moon to have matched at Yale Internal Medicine I cannot wait to experience and hopefully live up to: "As good as any, nicer than most" Mark D. Siegel (I can finally use this GIF! hope I do better than Rory!)

Dive into Novel Imaging and Biomarkers in #KidneyCancer at #KCRS24. Virtual seats are FREE! Register now. 🔗 bit.ly/KCRS24Register #AcceleratingCures

#KCRS24 Session 8: Rapid Abstract Presentations are underway! Tertiary Lymphoid Structures in Sarcomatoid RCC Nick Salgia Brain-Specific Tropism in mRCC Roy Elias Latino Ethnicity & Gut Microbiome in mRCC Regina Barragan-Carrillo #KidneyCancer #AcceleratingCures

We’re excited to share the final collection of visual notes by Ink Factory from #KCRS24! Their real-time lustrations have brilliantly captured the heart of our sessions, turning complex ideas into engaging visuals. Check out their amazing work and this!

Wrapped up #KCRS24 #AcceleratingCures 🏈⚽️! It was such a privilege to meet and learn from so many brilliant minds. Looking forward to #KCRS25 and continuing to advance renal cell carcinoma research! 🔬

#KCRS24 in 4 photos! KidneyCAN

Wrapping #kcrs24! Started my day with rock the run 5k and finished it with insightful discussions and inspiring moments. So glad to be part of kidney cancer research but also part of a great team along the way of curing this cancer!

Hello #MedTwitter #MedX I am Mohamad Ali Ibrahim, a USJ 🇱🇧 graduate and a research fellow at BCM Gastroenterology Excited to be applying for #InternalMedicine #Match2025 ! Looking forward to connecting with fellow applicants and programs

Hello #MedTwitter! I’m Eddy Saad, a USJ graduate 🇱🇧 and currently a postdoc fellow studying kidney cancer and immunotherapy 🤓 Dana-Farber Harvard Medical School Incredibly grateful for the opportunity to be applying for the #InternalMedicine #Match2025 ! AAMC ID: 16349429 #IMG

Hello #MedTwitter #MedX I am Razan Mohanna, a USJ 🇱🇧graduate and currently a research fellow at Brigham and Women's Hospital Harvard Medical School Excited to be applying for #InternalMedicine #Match2025 Looking forward for this journey and to connect with fellow applicants and programs!

The #WCRM has been reconvened introducing many new and incoming members to the Toni Choueiri, MD research group focused on #kidneycancer translational and clinical research. Welcome!

Thrilled to have presented our literature review on HHLA2 and its potential role in overcoming resistance to anti-PD1 at #esmoimmuno24 !Grateful to Dr. Freeman, Dr. Mahoney, and my mentor Dr. Signoretti for their invaluable contributions to advancing immuno-oncology.

🚨 New study! 🚨Excited to share our research on #translocationRCC #tRCC published in Nature Metabolism, in collaboration with @lironbarpeled. We reveal how the TFE3 fusion drives a key oxidative phosphorylation (OXPHOS) metabolic program in this kidney cancer. 1/ Dana-Farber News